
Hear how experienced physicians approach real cases
BackTable is the podcast-based learning platform for specialized healthcare providers. Get practical advice from your peers in the field.
Weekly conversations from leading voices in your specialty.

Vascular & IR
For interventional radiologists, vascular surgeons, and interventional cardiologists.

ENT & Allergy
For otolaryngologists, head and neck surgeons, and allergists.

Urology
For urologists, urologic oncologists, and urogynecologists.

Curbsiders
For internal medicine, primary care, family medicine, and hospitalists.

Cardiology
For medical cardiologists, cardiac surgeons, and interventional cardiologists.

CardioNerds
For anyone interested in the prevention and management of cardiovascular disease.

CathMasters
For practical interventional cardiology education.

Tumor Board
For medical oncologist, surgical oncologists, and radiation oncologists.

Women's Health
For OBGYNs, gynecologic surgeons, and women's health specialists.

Bone & Sports
For orthopedic surgeons, sports medicine docs, pain specialists, and MSK radiologists.

Litigation
For physicians navigating the complex world of medical malpractice lawsuits.

Industry
For healthcare leaders, business-minded providers, and innovators.
Podcasts
Tumor Board # 93Nov 19, 2026From Neoadjuvant and Perioperative Therapy to Surgery: Multidisciplinary Decisions in Early Stage NSCLC

“If I have a complete pathological response, why do I need to get surgery?” It is one of the hottest questions in early-stage non-small cell lung cancer (NSCLC), and Dr. John Lazar hears it from his patients after neoadjuvant therapy. On this episode of the BackTable Lung Cancer Creator Weekend™, medical oncologist Dr. Kate Baker talks with Dr. Lazar, thoracic surgeon at Ascension Saint Thomas, about who should get neoadjuvant or perioperative therapy and how tumor size, nodal disease, histology, and molecular profiling shape the plan. They also discuss what a complete pathologic response does and does not tell a patient, why waiting more than six weeks from diagnosis to treatment raises the risk of upstaging, and how surgery changes after treatment has distorted the anatomy.
Urology # 345Nov 19, 2026How to Excel at Urology Residency Interviews

If you're headed into urology residency interviews this season, here is one rule worth remembering: never tell more than one program it is your first choice. On this episode of the BackTable Urology Podcast, Dr. George Koch of Ohio State talks with Dr. Sarah Faris, program director at UChicago, and Dr. Lani Galloway, a urologic oncology fellow at Fox Chase, about how to prepare for residency interviews as many programs return to in-person interview days. They cover what virtual and in-person days look like, why the night-before social still counts, and how to prepare, from researching each program to explaining every publication on your CV in a few sentences.
Vascular & IR # 694Nov 17, 2026Musculoskeletal Embolization: New Frontiers & Techniques

Ten years ago, embolizing the knee for arthritis sounded insane, Dr. Ahmed Farag reminds the room, and today the same idea is being applied to the hip, shoulder, elbow, thumb, and even the spine. In the final session of the BackTable Creator Weekend™ on musculoskeletal (MSK) embolization, interventional radiologist Dr. Kavi Krishnasamy is joined by fellow interventional radiologists Dr. Osman Ahmed and Dr. Ahmed Farag to weigh what it takes to embolize a new target responsibly: experienced operators, a multidisciplinary team that agrees every other option is exhausted, careful documentation, and patients who have already responded well.
ENT & Allergy # 304Nov 17, 2026Early Recognition of EoE: A Multidisciplinary Roadmap

The more allergic conditions a patient has, such as asthma, eczema, or environmental allergies, the more likely it is that their trouble swallowing, chronic cough, or constant throat clearing comes from eosinophilic esophagitis (EoE), a condition that often goes years without a diagnosis. On this episode of the BackTable ENT & Allergy Podcast, allergist Dr. Basil Kahwash welcomes gastroenterologist Dr. Evan Dellon of the University of North Carolina at Chapel Hill and otolaryngologist Dr. Christine Franzese of the University of Missouri for the show's first multidisciplinary conversation on EoE. They explain why delayed diagnosis leads to strictures and food impactions and how EoE shows up in the ENT clinic as chronic cough, throat clearing, thick postnasal drainage, or a croupy cough in a child.
Cardiology # 60Nov 17, 2026Innovations in Coronary Intervention: Drug-Coated Balloons

In 1990, Dr. John Lasala watched one of the first coronary stents go into a failing artery and called it “the future of cardiology.” Now he and Dr. Aloke Finn see drug-coated balloons as a possible next shift: treating the artery without leaving a permanent implant behind. On this episode of BackTable Cardiology, Dr. Sameh Sayfo is joined by Dr. Lasala and Dr. Finn to trace coronary intervention from balloon angioplasty to drug-eluting stents, then explain how paclitaxel and sirolimus differ in the arterial wall and what it takes to keep sirolimus in the wall long enough to work. Dr. Lasala, who spent his early research career watching less than 1% of drug reach the vessel wall, admits that 20 years ago he would have called 90 days of drug retention impossible. They also explain why vessel preparation with imaging and specialty balloons must come first.
Women's Health # 140Nov 17, 2026Direct Contracting in Healthcare

Pitocin on an FDA shortage list is a problem every labor and delivery unit understands, and it was part of the cold email that pulled Mark Cuban into healthcare. On this episode of the BackTable Podcast, Dr. Ruchika Talwar, value-based care leader, talks with Mark Cuban, entrepreneur and founder of Mark Cuban Cost Plus Drug Company, about who actually sets the price of care in the United States. They trace how that start led to Cost Plus Drugs and then Cost Plus Wellness, an open source library of direct contracts between self-insured employers and providers, and why he believes the contract, not the published price, is where the real problems hide. They also discuss who really pays: by his estimate, 67% of people with job-based coverage get it through a self-insured employer.
Industry # 109Nov 12, 2026Direct Contracting in Healthcare

“Direct contract with yourself.” That is Mark Cuban's challenge to hospital CEOs and CFOs whose own self-insured health plans, he says, can pay a carrier-owned administrator more for an employee's care than the hospital itself was paid to provide it. On this episode of the BackTable Podcast, Dr. Ruchika Talwar, value-based care leader, talks with Mark Cuban, entrepreneur and founder of Mark Cuban Cost Plus Drug Company, about who actually sets the price of care in the United States. They trace how a cold email about drug shortages led to Cost Plus Drugs, a robotic factory that can switch manufacturing lines every four hours, and then Cost Plus Wellness, an open source library of direct contracts between self-insured employers and providers, and why he believes the contract, not the published price, is where the real problems hide. The discussion also covers who really pays: by his estimate, 67% of people with job-based coverage get it through a self-insured employer, and 72% of the big carriers' revenue comes from taxpayers.
Bone & Sports # 123Nov 10, 2026Controversies in GAE: Patient Selection Techniques

Could genicular artery embolization (GAE) one day be offered before knee osteoarthritis sets in, or before a knee replacement to ease recovery? These interventional radiologists do not all agree. On this episode of the BackTable 2026 MSK Creator Weekend™, Dr. Osman Ahmed, Dr. Ahmed Farag, and Dr. Ally Baheti work through the biggest debates in GAE, starting with the ideal candidate, when it is too early to offer the procedure, how they approach Kellgren-Lawrence grade 4 knees, when a repeat embolization makes sense, and whether MRI with or without contrast is needed before treatment.